INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
SJ
Sheena JonathanDirector, CO-FOUNDER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
191 sh
Jan 20, 2026Jan 22, 2026
Page 1469 of 1835
← PrevNext →
traded Jan 20, 2026
+2d
SEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M—
32.7K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M$138K
7,562 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
14.9K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,425 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$8,455
210 sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M—
13.9K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M$53K
13.9K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
16.2K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MP
Mauch Robert P.Director, President & CEO
CORCencora, Inc.
Option exercise · 10b5-1 plan
M—
3,763 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
26.6K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M—
7,562 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
BB
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
1,522 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
69.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
856 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
1,978 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence